Drug	Gene	Type	Source
cilostazol	CYP2C9	IC50=10.0(uM)	D1 PubChem
cilostazol	CYP3A4	Potency=12.5893(uM)	D1 PubChem
cilostazol	TDP1	Potency=16.3601(uM)	D1 PubChem
cilostazol	NFE2L2	Ratio Potency (uM)=18.8322(uM)	D1 PubChem
cilostazol	ALDH1A1	Potency=25.1189(uM)	D1 PubChem
cilostazol	TSHR	Potency=25.1189(uM)	D1 PubChem
cilostazol	CYP1A2	-	D1 PubChem
cilostazol	CYP3A4	-	D1 PubChem
cilostazol	NR5A1	-	D1 PubChem
cilostazol	CYP2C9	-	D1 PubChem
cilostazol	DRD1	-	D1 PubChem
cilostazol	NR5A2	-	D1 PubChem
cilostazol	NPY1R	-	D1 PubChem
cilostazol	NPY2R	-	D1 PubChem
cilostazol	PDE3A	-	D1 PubChem
cilostazol	CYP2D6	-	D1 PubChem
cilostazol	CYP2C19	-	D1 PubChem
cilostazol	CYP2C9	Inhibition=None(Unspecified)	D1 ChEMBL
cilostazol	CYP2C19	Inhibition=None(Unspecified)	D1 ChEMBL
cilostazol	CYP2D6	Inhibition=None(Unspecified)	D1 ChEMBL
cilostazol	CYP1A2	Inhibition=None(Unspecified)	D1 ChEMBL
cilostazol	CYP3A4	Potency=12589.3(nM)	D1 ChEMBL
cilostazol	ALDH1A1	Potency=25118.9(nM)	D1 ChEMBL
cilostazol	TSHR	Potency=25118.9(nM)	D1 ChEMBL
cilostazol	CYP3A4	AC50=12589.2(nM)	D1 ChEMBL